SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-007291
Filing Date
2019-02-13
Accepted
2019-02-13 17:00:38
Documents
5
Period of Report
2019-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv513485_8k.htm 8-K 25313
2 EXHIBIT 10.1 tv513485_ex10-1.htm EX-10.1 56928
3 EXHIBIT 99.1 tv513485_ex99-1.htm EX-99.1 10629
4 GRAPHIC logo.jpg GRAPHIC 5052
5 GRAPHIC logo2.jpg GRAPHIC 2145
  Complete submission text file 0001144204-19-007291.txt   104622
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 19598401
SIC: 2834 Pharmaceutical Preparations